Abstract

There remain significant gaps in clinical evidence in the management and treatment of peripheral artery disease (PAD). Many of these gaps exist as a result of ongoing challenges that exist in the implementation and design of clinical trials within the PAD clinical space. These challenges include the often-fragmented state of PAD clinical care, the frequent coexistence of other cardiovascular disease states, difficulties with recruiting PAD patients into clinical trials, a lack of diversity within PAD clinical trials, the limited focus of PAD clinical trials, and the sparse validation evidence of secondary endpoints and patient-reported outcomes measures in PAD trials.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call